Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
105.1 INR | -0.61% | -2.91% | +1.50% |
May. 13 | Ind-Swift Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
Apr. 19 | Ind-Swift Laboratories to Incorporate Wholly-Owned Arm in Dubai | MT |
Sales 2022 | 10.52B 126M | Sales 2023 | 12.16B 146M | Capitalization | 3.26B 39.21M |
---|---|---|---|---|---|
Net income 2022 | -21M -252K | Net income 2023 | 476M 5.72M | EV / Sales 2022 | 1.26 x |
Net Debt 2022 | 9.32B 112M | Net Debt 2023 | 8.44B 101M | EV / Sales 2023 | 0.96 x |
P/E ratio 2022 |
-183
x | P/E ratio 2023 |
6.85
x | Employees | 1,496 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 32.86% |
1 day | -0.61% | ||
1 week | -2.91% | ||
Current month | -12.16% | ||
1 month | -15.89% | ||
3 months | -1.31% | ||
6 months | +13.44% | ||
Current year | +1.50% |
Managers | Title | Age | Since |
---|---|---|---|
Navrattan Munjal
CEO | Chief Executive Officer | 72 | 95-01-03 |
Himanshu Jain
CEO | Chief Executive Officer | 41 | - |
Gagan Aggarwal
DFI | Director of Finance/CFO | - | 18-09-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Himanshu Jain
CEO | Chief Executive Officer | 41 | - |
Navrattan Munjal
CEO | Chief Executive Officer | 72 | 95-01-03 |
Director/Board Member | 68 | 09-08-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 105.1 | -0.61% | 239,132 |
24-05-27 | 105.8 | -0.09% | 201,046 |
24-05-24 | 105.8 | -1.81% | 336,780 |
24-05-23 | 107.8 | +0.51% | 220,558 |
24-05-22 | 107.2 | -0.92% | 277,902 |
Delayed Quote NSE India S.E., May 28, 2024 at 07:43 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+1.50% | 75.17M | |
+16.31% | 42.32B | |
+16.01% | 21.29B | |
+19.33% | 15.29B | |
+18.71% | 14.36B | |
+52.78% | 12.81B | |
-0.05% | 6.79B | |
-12.34% | 6.58B | |
-8.87% | 5.73B | |
+14.28% | 5.51B |
- Stock Market
- Equities
- INDSWFTLAB Stock